H. Lundbeck A/S (OTCMKTS:HLUYY – Get Free Report)’s stock price crossed above its fifty day moving average during trading on Friday . The stock has a fifty day moving average of $22.00 and traded as high as $24.00. H. Lundbeck A/S shares last traded at $22.00, with a volume of 7,500 shares.
H. Lundbeck A/S Stock Performance
The firm has a market capitalization of $21.91 billion, a price-to-earnings ratio of 25.00 and a beta of 0.68. The company has a fifty day moving average of $22.00 and a two-hundred day moving average of $22.00. The company has a debt-to-equity ratio of 0.32, a quick ratio of 0.71 and a current ratio of 1.15.
About H. Lundbeck A/S
H. Lundbeck A/S, a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, North America, and internationally. The company's principal products include Abilify Maintena for schizophrenia; Brintellix/Trintellix to treat depression; Northera for the treatment of symptomatic neurogenic orthostatic hypotension; Vyepti for migraine prevention; and Rexulti/Rxulti to treat depression/schizophrenia.
Read More
- Five stocks we like better than H. Lundbeck A/S
- Breakout Stocks: What They Are and How to Identify Them
- Symbotic Shares Down 37%—Is It Time for Bravery or Caution?
- REIT Stocks – Best REIT Stocks to Add to Your Portfolio Today
- High-Yield Healthcare: 3 Stocks With Strong Dividends
- How to Invest in Insurance Companies: A Guide
- Beyond the Bargain Bin: 3 Stocks Leading Discount Retail
Receive News & Ratings for H. Lundbeck A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H. Lundbeck A/S and related companies with MarketBeat.com's FREE daily email newsletter.
